In September, the U.S. Food and Drug 
Administration (FDA) granted market clearance for GE Healthcare’s MAGiC (MAGnetic resonance image Compilation) software, the industry’s first multi-contrast MRI technique that delivers eight contrasts in a single acquisition in a fraction of the time of conventional imaging. MAGiC is the result of a collaboration with SyntheticMR AB and gives clinicians more data than conventional scanning. This technique gives users the flexibility to manipulate MR images retrospectively, leading to significant timesavings, fewer rescans and therefore cost savings, which combined can assist the clinician in making a more decisive diagnosis. It uses an acquisition technique that allows the ability to modify image contrast after scanning has been completed, which is not possible with conventional MR. GE said MAGiC delivers more potential for the clinician to utilize changes in the image contrast to enhance their diagnosis and to reduce orders for rescans. Clinicians have the ability to generate multiple image contrasts in a single MR scan – including T1, T2, STIR, T1 FLAIR, T2 FLAIR, dual IR, phase sensitive IR and proton density weighted images of the brain in a single acquisition. To change the contrast, users simply move the cursor on the interface to change the parameters such as TR, TE and TI. MAGiC enables one scan that can do the work of many. MAGiC is available on GE’s Optima MR450, Optima MR450w, Discovery MR750, Discovery MR750w and Signa Pioneer MRI systems.
https://www.itnonline.com/article/recent-advances-mri-technology
